This Is Why with Dr. Busti Podcast Por Anthony Busti MD PharmD MSc FNLA FAHA arte de portada

This Is Why with Dr. Busti

This Is Why with Dr. Busti

De: Anthony Busti MD PharmD MSc FNLA FAHA
Escúchala gratis

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

This Is Why exists to help medical professionals understand the why behind the decisions they make every day in patient care. Our approach is about integrating evidence, clinical relevance and real-world application so that what your learn connects directly with the patients you serve.

© 2026 This Is Why with Dr. Busti
Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • GPIIb/IIIa Inhibitors: Antiplatelet Pharmacology Made Easy & Relevant
    Jan 16 2026

    In this lesson on glycoprotein (GP) IIb/IIIa (GPIIb/IIIa) inhibitors, you’ll learn the high-yield, test-relevant concepts behind the adjunct antiplatelet drug therapy used in the acute management of patients experiencing an acute myocardial infarction (AMI; NSTEMI, STEMI) and undergoing PCI or coronary stent placement. In this lecture from This is Why, Dr. Busti will break down how platelet aggregation inhibitors work, when they’re used clinically, and the key differences between tirofiban and eptifibatide —so you can apply the “why” behind therapy (not just memorize drug names).


    You’ll learn how to:

    - The GPIIb/IIIa receptor and how blocking it reduces platelet activation

    - Where GPIIb/IIIa inhibitors fit in clinical practice

    - High-yield uses: acute coronary syndrome (ACS) and PCI/stents

    - Major adverse effects (including bleeding) and top safety pearls


    The goal = make medical education easy and clinically relevant.


    Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/gpiibiiia-inhibitors-tirofiban-eptifibatide-antiplatelet-pharmacology-review


    Get more with a free membership at https://www.thisiswhy.health/

    - Access free downloads from our videos

    - Access deep dive content from Dr. Busti

    - Organize content via playlists & collections

    - Join live Q&A

    - Receive member newsletters

    - Coupons & discounts for exam prep resources


    If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.


    Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!


    #gpiibiiiainhibitors #tirofiban #antiplateletpharmacology #eptifibatide #drbusti


    Disclaimer:

    This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

    Más Menos
    17 m
  • P2Y12 Inhibitors (ADP Inhibitors): Antiplatelet Pharmacology Made Easy
    Jan 16 2026

    In this lesson on P2Y12 inhibitors (ADP inhibitors), you’ll learn the high-yield, test-relevant concepts behind the most common antiplatelet drugs used in cardiovascular care. In this lecture from This is Why, Dr. Busti will break down how platelet aggregation inhibitors work, when they’re used clinically, and the key differences between clopidogrel (Plavix), prasugrel (Effient), ticagrelor (Brilinta), and cangrelor (Kengreal)—so you can apply the “why” behind therapy (not just memorize drug names).


    You’ll learn how to:

    - The P2Y12 (ADP) receptor and how blocking it reduces platelet activation

    - Where P2Y12 inhibitors fit in dual antiplatelet therapy (DAPT)

    - High-yield uses: acute coronary syndrome (ACS), PCI/stents, and secondary prevention

    - Major adverse effects (including bleeding) and top safety pearls

    - The exam-favorite comparisons: prodrug activation, onset/offset, reversibility, and IV vs PO options


    The goal = make medical education easy and clinically relevant.


    Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/p2y12-adp-inhibitors-antiplatelet-pharmacology-review


    Get more with a free membership at https://www.thisiswhy.health/

    - Access free downloads from our videos

    - Access deep dive content from Dr. Busti

    - Organize content via playlists & collections

    - Join live Q&A

    - Receive member newsletters

    - Coupons & discounts for exam prep resources


    If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.


    Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!


    #p2y12inhibitors #clopidogrel #antiplateletpharmacology #ticagrelor #drbusti


    Disclaimer:

    This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

    Más Menos
    44 m
  • Aspirin (ASA): Antiplatelet Pharmacology Made Easy & Relevant
    Jan 15 2026

    Master Aspirin (ASA) fast with this Antiplatelet Pharmacology Made Easy & Relevant lecture. In this lecture from This is Why, Dr. Busti will make sure you learn how acetylsalicylic acid works as an antiplatelet drug, including COX-1 inhibition, decreased thromboxane A2 (TXA2), and reduced platelet aggregation—plus the key clinical takeaways for MI prevention, stroke prevention, and secondary prevention.

    You’ll learn how to:
    - Aspirin mechanism of action (COX inhibitor → ↓ TXA2 → ↓ platelet aggregation)
    - Why aspirin is different from other NSAIDs in antiplatelet therapy
    - High-yield uses in cardiovascular pharmacology (MI/stroke prevention)
    - Side effects, contraindications, and safety pearls you need for exams

    The goal = make medical education easy and clinically relevant.

    👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/aspirin-asa-salicylic-acid-antiplatelet-pharmacology-review

    👉 Get more with a free membership at https://www.thisiswhy.health/
    - Access free downloads from our videos
    - Access deep dive content from Dr. Busti
    - Organize content via playlists & collections
    - Join live Q&A
    - Receive member newsletters
    - Coupons & discounts for exam prep resources

    👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

    🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

    #aspirin #asa #aspirinpharmacology #antiplateletdrugspharmacology #drbusti

    Disclaimer:
    This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

    Más Menos
    43 m
Todavía no hay opiniones